EP Patent

EP3035914A1 — Pharmaceutical compositions comprising bortezomib

Assigned to Synthon BV · Expires 2016-06-29 · 10y expired

What this patent protects

The present invention relates to pharmaceutical compositions for parenteral administration of bortezomib, comprising an admixture of bortezomib with sodium gluconate.

USPTO Abstract

The present invention relates to pharmaceutical compositions for parenteral administration of bortezomib, comprising an admixture of bortezomib with sodium gluconate.

Drugs covered by this patent

Patent Metadata

Patent number
EP3035914A1
Jurisdiction
EP
Classification
—
Expires
2016-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Synthon BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.